4//SEC Filing
Drugs Made In America Acquisition LLC 4
Accession 0001213900-25-015020
CIK 0002028614other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 9:55 PM ET
Size
7.5 KB
Accession
0001213900-25-015020
Insider Transaction Report
Form 4
Transactions
- Purchase
Ordinary shares
2025-02-18+30,000→ 4,188,780 total - Purchase
Rights to receive ordinary shares
2025-02-18+30,000→ 430,000 total→ Ordinary shares (30,000 underlying)
Footnotes (2)
- [F1]Reflects the 30,000 private units acquired by the reporting person, the Issuer's sponsor. Each private unit consists of one ordinary share and one right to receive one-eighth (1/8) of an ordinary share upon the consummation of an initial business combination. The private units were purchased at $10 per unit for an aggregate purchase price of $300,000.
- [F2]The rights convert automatically into ordinary shares at the completion of the Issuer's initial business combination.
Documents
Issuer
Drugs Made In America Acquisition Corp.
CIK 0002028614
Entity typeother
Related Parties
1- filerCIK 0002038492
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 9:55 PM ET
- Size
- 7.5 KB